 Bennie Lindeque
Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prosthesis-Related Infections | 5 | 2019 | 71 | 1.370 |
Why?
| | Bone Neoplasms | 5 | 2014 | 194 | 1.350 |
Why?
| | Mycobacterium Infections, Nontuberculous | 3 | 2019 | 333 | 1.150 |
Why?
| | Hip Prosthesis | 3 | 2015 | 33 | 0.960 |
Why?
| | Nontuberculous Mycobacteria | 2 | 2019 | 204 | 0.960 |
Why?
| | Sarcoma | 2 | 2021 | 138 | 0.950 |
Why?
| | Knee Joint | 3 | 2016 | 323 | 0.940 |
Why?
| | Arthroplasty, Replacement, Hip | 2 | 2015 | 109 | 0.840 |
Why?
| | Nylons | 1 | 2022 | 18 | 0.830 |
Why?
| | Knee Prosthesis | 2 | 2014 | 15 | 0.830 |
Why?
| | Orthopedic Procedures | 2 | 2014 | 207 | 0.790 |
Why?
| | Suture Techniques | 1 | 2022 | 115 | 0.780 |
Why?
| | Nocardia Infections | 1 | 2021 | 7 | 0.770 |
Why?
| | Thoracic Wall | 1 | 2021 | 14 | 0.760 |
Why?
| | Prostheses and Implants | 2 | 2014 | 138 | 0.710 |
Why?
| | Tibial Fractures | 4 | 2010 | 67 | 0.710 |
Why?
| | Carcinoma, Renal Cell | 1 | 2021 | 173 | 0.660 |
Why?
| | Arthroplasty, Replacement, Knee | 2 | 2014 | 246 | 0.640 |
Why?
| | Fracture Fixation, Intramedullary | 2 | 2010 | 54 | 0.630 |
Why?
| | Musculoskeletal Diseases | 1 | 2019 | 54 | 0.620 |
Why?
| | Tertiary Care Centers | 1 | 2019 | 126 | 0.620 |
Why?
| | Osseointegration | 1 | 2018 | 37 | 0.590 |
Why?
| | Kidney Neoplasms | 1 | 2021 | 333 | 0.580 |
Why?
| | Antitubercular Agents | 2 | 2019 | 169 | 0.570 |
Why?
| | Thermal Conductivity | 1 | 2016 | 5 | 0.560 |
Why?
| | Cancellous Bone | 1 | 2016 | 20 | 0.560 |
Why?
| | Cortical Bone | 1 | 2016 | 18 | 0.550 |
Why?
| | Prosthesis Implantation | 1 | 2018 | 139 | 0.550 |
Why?
| | Freezing | 1 | 2016 | 85 | 0.540 |
Why?
| | Body Temperature | 1 | 2016 | 208 | 0.530 |
Why?
| | Fracture Fixation, Internal | 2 | 2010 | 194 | 0.520 |
Why?
| | Artificial Limbs | 1 | 2018 | 116 | 0.510 |
Why?
| | Tenosynovitis | 1 | 2015 | 12 | 0.490 |
Why?
| | Osteoarthritis, Hip | 1 | 2015 | 39 | 0.470 |
Why?
| | Cryosurgery | 2 | 2014 | 52 | 0.470 |
Why?
| | Osteotomy | 3 | 2016 | 146 | 0.450 |
Why?
| | Arthritis, Infectious | 1 | 2014 | 49 | 0.450 |
Why?
| | Staphylococcal Infections | 2 | 2008 | 336 | 0.450 |
Why?
| | Carbon | 1 | 2014 | 157 | 0.450 |
Why?
| | Osteochondroma | 2 | 2010 | 7 | 0.440 |
Why?
| | Skin Temperature | 1 | 2013 | 16 | 0.440 |
Why?
| | Splints | 1 | 2013 | 11 | 0.440 |
Why?
| | Casts, Surgical | 1 | 2013 | 28 | 0.430 |
Why?
| | Prosthesis Design | 4 | 2018 | 285 | 0.430 |
Why?
| | Biomedical Research | 2 | 2011 | 585 | 0.430 |
Why?
| | Bone Density | 1 | 2016 | 432 | 0.430 |
Why?
| | Body Temperature Regulation | 1 | 2013 | 72 | 0.420 |
Why?
| | Tibia | 2 | 2016 | 166 | 0.410 |
Why?
| | Terrorism | 1 | 2012 | 25 | 0.410 |
Why?
| | Muscle Neoplasms | 1 | 2012 | 8 | 0.400 |
Why?
| | Financial Support | 1 | 2011 | 18 | 0.380 |
Why?
| | Health Care Sector | 1 | 2011 | 24 | 0.380 |
Why?
| | Surgical Wound Infection | 1 | 2014 | 248 | 0.380 |
Why?
| | Private Sector | 1 | 2011 | 51 | 0.380 |
Why?
| | Risk Assessment | 3 | 2011 | 2973 | 0.370 |
Why?
| | Humans | 34 | 2022 | 114709 | 0.370 |
Why?
| | Bone Cements | 1 | 2011 | 35 | 0.370 |
Why?
| | Drug Implants | 1 | 2011 | 70 | 0.370 |
Why?
| | Social Change | 1 | 2010 | 13 | 0.360 |
Why?
| | Triage | 1 | 2012 | 192 | 0.350 |
Why?
| | Anti-Bacterial Agents | 2 | 2011 | 1477 | 0.350 |
Why?
| | Fibula | 1 | 2010 | 41 | 0.340 |
Why?
| | Wounds, Gunshot | 1 | 2012 | 188 | 0.330 |
Why?
| | Orthopedics | 1 | 2011 | 121 | 0.330 |
Why?
| | Bone Plates | 1 | 2010 | 75 | 0.330 |
Why?
| | Bone Nails | 1 | 2009 | 58 | 0.310 |
Why?
| | Education, Medical, Undergraduate | 1 | 2010 | 159 | 0.310 |
Why?
| | Salvage Therapy | 1 | 2009 | 127 | 0.300 |
Why?
| | Tensile Strength | 2 | 2022 | 88 | 0.290 |
Why?
| | Extremities | 1 | 2008 | 113 | 0.290 |
Why?
| | Chondrosarcoma | 1 | 2007 | 12 | 0.280 |
Why?
| | Evidence-Based Medicine | 1 | 2011 | 667 | 0.280 |
Why?
| | Fractures, Comminuted | 1 | 2006 | 25 | 0.270 |
Why?
| | Embryo Research | 1 | 2006 | 1 | 0.270 |
Why?
| | Biotechnology | 1 | 2006 | 41 | 0.260 |
Why?
| | Cross Infection | 1 | 2007 | 197 | 0.250 |
Why?
| | Hip Fractures | 1 | 2006 | 75 | 0.250 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2008 | 191 | 0.250 |
Why?
| | Academic Medical Centers | 1 | 2008 | 413 | 0.250 |
Why?
| | Femoral Artery | 1 | 2006 | 167 | 0.250 |
Why?
| | Liability, Legal | 1 | 2005 | 38 | 0.250 |
Why?
| | Stem Cell Transplantation | 1 | 2006 | 149 | 0.250 |
Why?
| | Malpractice | 1 | 2005 | 37 | 0.250 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3031 | 0.230 |
Why?
| | Cell Culture Techniques | 1 | 2006 | 343 | 0.220 |
Why?
| | Cadaver | 2 | 2022 | 299 | 0.220 |
Why?
| | Colorado | 4 | 2019 | 4085 | 0.210 |
Why?
| | Atherosclerosis | 1 | 2006 | 342 | 0.210 |
Why?
| | Practice Guidelines as Topic | 1 | 2010 | 1393 | 0.210 |
Why?
| | Delivery of Health Care | 1 | 2009 | 833 | 0.200 |
Why?
| | Sutures | 1 | 2022 | 50 | 0.200 |
Why?
| | Tissue Engineering | 1 | 2006 | 364 | 0.200 |
Why?
| | Biomechanical Phenomena | 2 | 2022 | 667 | 0.200 |
Why?
| | Stem Cells | 1 | 2006 | 546 | 0.200 |
Why?
| | Cryotherapy | 1 | 2021 | 16 | 0.190 |
Why?
| | Thigh | 1 | 2021 | 53 | 0.190 |
Why?
| | Equipment Failure Analysis | 2 | 2013 | 132 | 0.190 |
Why?
| | Middle Aged | 8 | 2021 | 26747 | 0.190 |
Why?
| | Aged | 6 | 2019 | 19078 | 0.180 |
Why?
| | Reoperation | 2 | 2014 | 514 | 0.180 |
Why?
| | Aged, 80 and over | 4 | 2019 | 6346 | 0.180 |
Why?
| | Risk Factors | 5 | 2014 | 8625 | 0.170 |
Why?
| | Immunocompromised Host | 1 | 2021 | 195 | 0.170 |
Why?
| | Public Health Surveillance | 1 | 2019 | 61 | 0.160 |
Why?
| | Female | 11 | 2019 | 59483 | 0.160 |
Why?
| | Male | 9 | 2021 | 55554 | 0.150 |
Why?
| | Amputation Stumps | 1 | 2018 | 8 | 0.150 |
Why?
| | Symptom Assessment | 1 | 2019 | 118 | 0.150 |
Why?
| | Suture Anchors | 1 | 2018 | 31 | 0.150 |
Why?
| | Prosthesis Failure | 1 | 2018 | 117 | 0.140 |
Why?
| | Weight-Bearing | 1 | 2018 | 165 | 0.140 |
Why?
| | Amputees | 1 | 2018 | 62 | 0.140 |
Why?
| | Patellar Dislocation | 1 | 2016 | 6 | 0.130 |
Why?
| | Patella | 1 | 2016 | 22 | 0.130 |
Why?
| | Patellar Ligament | 1 | 2016 | 22 | 0.130 |
Why?
| | Necrosis | 1 | 2016 | 210 | 0.130 |
Why?
| | Tendon Transfer | 1 | 2016 | 43 | 0.130 |
Why?
| | Treatment Outcome | 3 | 2018 | 9089 | 0.130 |
Why?
| | Femur | 1 | 2016 | 191 | 0.130 |
Why?
| | Benzophenones | 1 | 2014 | 16 | 0.120 |
Why?
| | Internal Fixators | 1 | 2014 | 36 | 0.120 |
Why?
| | Ketones | 1 | 2014 | 45 | 0.120 |
Why?
| | Reproducibility of Results | 1 | 2021 | 2762 | 0.110 |
Why?
| | Elasticity | 1 | 2014 | 189 | 0.110 |
Why?
| | Retrospective Studies | 2 | 2021 | 12511 | 0.110 |
Why?
| | Prevalence | 2 | 2011 | 2249 | 0.110 |
Why?
| | Healthy Volunteers | 1 | 2013 | 197 | 0.100 |
Why?
| | Incidence | 2 | 2008 | 2312 | 0.100 |
Why?
| | Equipment Design | 1 | 2013 | 508 | 0.090 |
Why?
| | Polymers | 1 | 2014 | 447 | 0.090 |
Why?
| | Training Support | 1 | 2010 | 22 | 0.090 |
Why?
| | Research Support as Topic | 1 | 2011 | 108 | 0.090 |
Why?
| | Polyethylene Glycols | 1 | 2014 | 561 | 0.090 |
Why?
| | Costs and Cost Analysis | 1 | 2010 | 195 | 0.090 |
Why?
| | Patient Positioning | 1 | 2010 | 42 | 0.080 |
Why?
| | Thumb | 1 | 1990 | 24 | 0.080 |
Why?
| | Young Adult | 2 | 2019 | 10461 | 0.080 |
Why?
| | Arthralgia | 1 | 2010 | 46 | 0.080 |
Why?
| | Conflict of Interest | 1 | 2011 | 119 | 0.080 |
Why?
| | United States | 3 | 2010 | 12175 | 0.080 |
Why?
| | History, 20th Century | 1 | 2010 | 265 | 0.080 |
Why?
| | Adult | 5 | 2019 | 30542 | 0.080 |
Why?
| | Europe | 1 | 2009 | 336 | 0.080 |
Why?
| | Arthroscopy | 1 | 2010 | 200 | 0.080 |
Why?
| | Methicillin Resistance | 1 | 2007 | 18 | 0.070 |
Why?
| | Prospective Studies | 2 | 2018 | 6215 | 0.070 |
Why?
| | Rare Diseases | 1 | 2008 | 89 | 0.070 |
Why?
| | Osteoarthritis, Knee | 1 | 2010 | 213 | 0.070 |
Why?
| | Hospital Costs | 1 | 2007 | 103 | 0.070 |
Why?
| | Embolism, Fat | 1 | 1987 | 10 | 0.070 |
Why?
| | Methylprednisolone | 1 | 1987 | 82 | 0.070 |
Why?
| | Clinical Trials as Topic | 1 | 2011 | 934 | 0.070 |
Why?
| | Intraoperative Complications | 1 | 2006 | 121 | 0.060 |
Why?
| | Staphylococcus aureus | 1 | 2007 | 385 | 0.060 |
Why?
| | Biopsy | 1 | 2007 | 1040 | 0.050 |
Why?
| | Fractures, Open | 1 | 2002 | 26 | 0.050 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2002 | 132 | 0.050 |
Why?
| | Transforming Growth Factor beta | 1 | 2002 | 449 | 0.040 |
Why?
| | Adolescent | 3 | 2008 | 17806 | 0.030 |
Why?
| | Arthrodesis | 1 | 1990 | 105 | 0.020 |
Why?
| | Radiography | 1 | 1990 | 811 | 0.020 |
Why?
| | Complement C5 | 1 | 1987 | 73 | 0.020 |
Why?
| | Femoral Fractures | 1 | 1987 | 67 | 0.020 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1987 | 151 | 0.020 |
Why?
| | Random Allocation | 1 | 1987 | 335 | 0.020 |
Why?
| | Syndrome | 1 | 1987 | 334 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 1990 | 1340 | 0.020 |
Why?
| | Double-Blind Method | 1 | 1987 | 1662 | 0.010 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2002 | 75 | 0.010 |
Why?
| | Oxygen | 1 | 1987 | 853 | 0.010 |
Why?
| | Single-Blind Method | 1 | 2002 | 258 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2002 | 1233 | 0.010 |
Why?
|
|
Lindeque's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|